Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2003 1
2004 1
2007 2
2008 1
2009 1
2011 1
2012 1
2013 1
2015 1
2017 1
2019 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
França TT, Barreiros LA, Al-Ramadi BK, Ochs HD, Cabral-Marques O, Condino-Neto A. França TT, et al. Expert Rev Clin Immunol. 2019 May;15(5):529-540. doi: 10.1080/1744666X.2019.1573674. Epub 2019 Feb 18. Expert Rev Clin Immunol. 2019. PMID: 30681380 Review.
Despite currently available treatments, CD40L-deficient patients remain susceptible to life-threatening infections and have poor long term survival. Areas covered: Here, we discuss clinical and immunological characteristics of CD40L deficiency as well as current therapeuti …
Despite currently available treatments, CD40L-deficient patients remain susceptible to life-threatening infections and have poor long term s …
Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
Allewelt H, Martin PL, Szabolcs P, Chao N, Buckley R, Parikh S. Allewelt H, et al. Pediatr Blood Cancer. 2015 Dec;62(12):2216-22. doi: 10.1002/pbc.25711. Epub 2015 Aug 20. Pediatr Blood Cancer. 2015. PMID: 26291959 Clinical Trial.
CONCLUSIONS: Allogeneic HSCT results in excellent survival and sustained immune reconstitution in patients with CD40 ligand deficiency using both myeloablative and reduced intensity conditioning approaches and various graft sources, including bone marrow, per …
CONCLUSIONS: Allogeneic HSCT results in excellent survival and sustained immune reconstitution in patients with CD40 ligand …
Cryptosporidium spp. Infection in Solid Organ Transplantation: The Nationwide "TRANSCRYPTO" Study.
Lanternier F, Amazzough K, Favennec L, Mamzer-Bruneel MF, Abdoul H, Tourret J, Decramer S, Zuber J, Scemla A, Legendre C, Lortholary O, Bougnoux ME; ANOFEL Cryptosporidium National Network and Transplant Cryptosporidium Study Group. Lanternier F, et al. Transplantation. 2017 Apr;101(4):826-830. doi: 10.1097/TP.0000000000001503. Transplantation. 2017. PMID: 27681270 Free PMC article.
Five patients had additional immunodepression favoring cryptosporidiosis (CD40 ligand deficiency [n = 1], human immunodeficiency virus infection [n = 4]). ...
Five patients had additional immunodepression favoring cryptosporidiosis (CD40 ligand deficiency [n = 1], human immunod …
CD40 ligand deficiency: neurologic sequelae with radiographic correlation.
Bishu S, Madhavan D, Perez P, Civitello L, Liu S, Fessler M, Holland SM, Jain A, Pao M. Bishu S, et al. Pediatr Neurol. 2009 Dec;41(6):419-27. doi: 10.1016/j.pediatrneurol.2009.07.003. Pediatr Neurol. 2009. PMID: 19931163 Free PMC article.
Characterizing the central nervous system complications of immune deficiencies can lead to the identification of new pathogens. For this study, clinical data were reviewed on patients with both CD40 ligand deficiency and neurodegeneration, identified f …
Characterizing the central nervous system complications of immune deficiencies can lead to the identification of new pathogens. For this stu …
Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy.
Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, Amirzagar AA, Futatani T, Miyawaki M. Atarod L, et al. Iran J Allergy Asthma Immunol. 2007 Mar;6(1):37-40. Iran J Allergy Asthma Immunol. 2007. PMID: 17303928 Free article.
Hyper-IgM syndromes are characterized by profound reduction of serum IgG, IgA, and IgE levels with normal or increased concentrations of serum IgM. CD40 ligand deficiency is X-linked form of the disease, which results in a lack of immunoglobulin class switchi …
Hyper-IgM syndromes are characterized by profound reduction of serum IgG, IgA, and IgE levels with normal or increased concentrations of ser …
Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002.
Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ, Davies EG. Gennery AR, et al. Blood. 2004 Feb 1;103(3):1152-7. doi: 10.1182/blood-2003-06-2014. Epub 2003 Oct 2. Blood. 2004. PMID: 14525761 Free article.
Nonmyeloablative stem cell transplantation for congenital immunodeficiencies.
Amrolia P, Gaspar HB, Hassan A, Webb D, Jones A, Sturt N, Mieli-Vergani G, Pagliuca A, Mufti G, Hadzic N, Davies G, Veys P. Amrolia P, et al. Blood. 2000 Aug 15;96(4):1239-46. Blood. 2000. PMID: 10942363 Free article.
The rate of immune reconstitution is comparable with that of historical controls undergoing standard myeloablative protocols. Two patients with CD40 ligand deficiency now show significant expression, and a patient with adenosine deaminase deficiency has impro …
The rate of immune reconstitution is comparable with that of historical controls undergoing standard myeloablative protocols. Two patients w …
13 results